Assessing the Impact of Topical Steroids on Tinea Infections: An Epidemiological Investigation

Year : 2024 | Volume :01 | Issue : 01 | Page : 10-18
By

Gauri H. Uplenchwar1

Abstract

This retrospective epidemiological study investigates the prevalence and characteristics of modified tinea infections resulting from the use of topical steroids. Analyzing patient records from October 2022 at ‘District General Hospital, Amravati, the study reveals a significant association between topical steroid use and altered clinical features in 89% of cases. Factors such as steroid potency, duration of use, and specific tinea subtypes affected contribute to understanding the epidemiology of modified tinea infections. Patient counseling plays an important role in the fast recovery of such patients. Healthcare providers should take into account the past use of steroids when diagnosing and treating tinea infections, underscoring the importance of additional research to guide evidence-based protocols. It is recommended that medical professionals consider the patient’s past use of steroids while identifying and treating tinea infections. This emphasizes the need for more investigation to clarify the specifics of this relationship and to guide evidence-based practices. These kinds of studies are essential for expanding our knowledge of the difficulties associated with identifying and treating tinea infections, which will ultimately lead to better patient treatment and results. Through the integration of findings from both this study and upcoming research endeavors, medical professionals will be able to formulate more knowledgeable strategies for the diagnosis and treatment of tinea infections, which will maximize treatment effectiveness and foster patient welfare.

Keywords: Dermatophytes, Topical steroid misuse, Tinea incognito, Steroid-modified tinea, Corticosteroids

[This article belongs to International Journal of Vaccines(ijv)]

How to cite this article: Gauri H. Uplenchwar1. Assessing the Impact of Topical Steroids on Tinea Infections: An Epidemiological Investigation. International Journal of Vaccines. 2024; 01(01):10-18.
How to cite this URL: Gauri H. Uplenchwar1. Assessing the Impact of Topical Steroids on Tinea Infections: An Epidemiological Investigation. International Journal of Vaccines. 2024; 01(01):10-18. Available from: https://journals.stmjournals.com/ijv/article=2024/view=135641

References

  1. Kedia, S., & Mathur, M. (2010). Tinea incognito: Report of two cases. Journal of College of Medical Sciences-Nepal, 6(3), 46–49.
  2. Thota S, Dr. Nirupama, Clinical profile of steroid misuse in tinea: a cross sectional study. International Journal of Scientific Reasearch. Vol-10, March – 2021:53-55.
  3. AS Kalsi, R Thakur, P Kushwaha. Corticosteroid – modified Dermatophytosis – a unique presentation . J DermatCosmetol. 2019;3(4):100-102.
  4. Kothiwal R, Dr. Yadav R.Trends of steroid modified tinea at tertiary care hospital in India. International Multi-speciality Journal of Health (IMJH), Vol-3, Issue -7, July-2017:263-267.
  5. Agarwal US, Saran J, Agarwal P. Clinico-mycological study of dermatophytes in a tertiary care centre in northwest India. Indian J Dermatol Venereol Leprol 2014; 80:194.
  6. Verma SB, Panda S, Nen Dermatology , Rudramurthy SM, Uhrlass S, et al. The unprecedented epidemic- like scenario of Dermatophytosis in India: I. Epidemiological, Risk factors and clinical features. Indian J Dermatol Venerol Leprol 2021; 87:154-175.
  7. Gupta M. Topical corticosteroid abuse – a prospective clinico- epidemiological study. Our Dermatol Online .2019; 10(2):142-144.
  8. Saraswat A. Lahore K. Topical corticosteroid abuse on the face: A prospective, multicenter study of dermatology outpatients. Indian Journal of Dermatology, Venereology and Leprology · March 2011, vol 77. Issue 2.
  9. Nivedha A, Kaviaransan PK, ET al. Clinicoepidemiological profile of steroid modified dermatophytosis following abuse of irrational combination of topical corticosteroid containing preparations (ICSP). IP Indian Journal of Clinical and Experimental Dermatology, May 2020.
  10. P Bains Topical corticosteroid abuse on face: a clinical study of 100 patients Int J Res Dermatol , Nov 2021, vol 10, Issue 11.
  11. Lakhani SJ, Bilimoria F, Lakhani JD. Adverse effects of steroid use in dermatophytic infections: a cross sectional study. J Integr Health Sci 2017; 5:63-8.
  12. Mahajan S, Tilak R, Kaushal SK, Mishra RN, Pandey SS. Clinico-mycological study of dermatophytic infections and their sensitivity to antifungal drugs in a tertiary care center. Indian J Dermatol Venereol Leprol [serial online] 2017 [cited 2019 Sep 12];83:436-40.
  13. Mahar S, Mahajan K, Agarwal S, Kar HK, Bhattacharya SK Topical Corticosteroid Misuse: The Scenario in Patients Attending a Tertiary Care Hospital in New Delhi.J Clin Diagn Res. 2016 Dec;10(12):FC16-FC20.
  14. Hanumanthappa H, Sarojini K, Shilpashree P, Muddapur SB. Clinicomycological study of 150 cases of dermatophytosis in a tertiary care hospital in South India. Indian J Dermatol 2012; 57:322-3.
  15. Kaur R, Panda PS, Sardana K, Khan S. Mycological pattern of dermatomycoses in a tertiary care hospital. J Trop Med 2015; 2015:157828.
Regular Issue Subscription Original Research
Volume 01
Issue 01
Received March 11, 2024
Accepted March 14, 2024
Published March 28, 2024
Views: 75